Minimally invasive versus open pancreatoduodenectomy in benign, premalignant, and malignant disease.
| Autor: | Riviere D; Department of Medical Imaging, Radboud University Medical Center Nijmegen, Nijmegen, Netherlands., van den Boezem PB; Department of Surgery, Radboud University Medical Center, Nijmegen, Netherlands., Besselink MG; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands., van Laarhoven CJ; Department of Surgery, Radboud University Medical Center, Nijmegen, Netherlands., Kooby DA; Department of Surgery, Emory University School of Medicine, Atlanta, GA, USA., Vollmer CM; Department of Gastrointestinal Surgery, University of Pennsylvania, Philadelphia, PA, USA., Davidson BR; Division of Surgery and Interventional Science, University College London, London, UK., Gurusamy KS; Division of Surgery and Interventional Science, University College London, London, UK. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2024 Jul 26; Vol. 7. Cochrane AN: CD014017. Date of Electronic Publication: 2024 Jul 26. |
| DOI: | 10.1002/14651858.CD014017 |
| Abstrakt: | Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of laparoscopic or robot-assisted pancreatoduodenectomy versus open pancreatoduodenectomy for people with benign, premalignant, and malignant disease. (Copyright © 2024 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|